RE: Mick.............4 Jan 2022 16:33
British pharmaceutical firm GW has been sold to US rival Jazz Pharmaceuticals for $7.2bn (£5.3bn), sending shares in the Cambridge-based company soaring. Jazz will acquire GW for $220 per American depository share, with $200 paid in cash and the remaining $20 in Jazz shares.